NCT03830463View on ClinicalTrials.gov

Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

March 28, 2019

Study Completion Date

March 28, 2019

Conditions
Healthy
Interventions
DRUG

CTP-692

Single oral dose

DRUG

Placebo

Single oral dose

Trial Locations (1)

90806

Collaborative Neuroscience Network, LLC, Long Beach

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT03830463 - Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers | Biotech Hunter | Biotech Hunter